Skip to search formSkip to main contentSkip to account menu

Typhim VI

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children
Background: The assessment of specific polysaccharide antibody production plays a pivotal role in the diagnosis of humoral… 
Review
2019
Review
2019
Combined vaccines for prophylaxis of infectious conditions
Abstract In recent years, the application of vaccines shows limitations, including the high number of vaccine administrations and… 
2015
2015
A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
2012
2012
Comparative Tolerability and Immunogenicity of TypherixTM or Typhim Vi™ in Healthy Adults
AbstractBackground: This study was carried out to compare the immunogenicity and tolerability of Typherix™, a recently developed… 
2010
2010
Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever.
2008
2008
Seroprevalence of anti Vi antibodies and immunogenicity of Typhim Vi vaccine in children
This prospective study was carried out on 250 children between 6 months to 5 years of age to determine seroprevalence of anti Vi… 
2008
2008
Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight.
2007
2007
Safety of Typhim Vi vaccine in a postmarketing observational study.
BACKGROUND Typhoid fever is endemic in many parts of the world. In the United States, nearly three quarters of all cases are… 
2001
2001
Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration.
BACKGROUND This study was carried out to compare the immunogenicity and tolerability of Typherix, a recently developed typhoid Vi… 
1995
1995
Typhim Vi: A New Typhoid Vaccine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)